• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Prevention and treatment of cytomegalovirus infection and disease after bone marrow transplantation in the 1990s.

作者信息

Winston D J, Gale R P

机构信息

Department of Medicine, UCLA Medical Center 90024-1678.

出版信息

Bone Marrow Transplant. 1991 Jul;8(1):7-11.

PMID:1655140
Abstract

There is substantial progress in preventing and treating cytomegalovirus (CMV) infections and CMV-related disease after allogeneic bone marrow transplantation. In CMV-seronegative recipients, use of CMV-seronegative blood products eliminates most CMV infections. Effective prophylaxis for CMV-seropositive recipients is being studied. Preliminary results of controlled trials of prophylactic ganciclovir show reduced CMV-related interstitial pneumonia. Intravenous immunoglobulin (i.v.IG) may further reduce risk of interstitial pneumonia in both CMV-seronegative and -seropositive recipients by decreasing graft-versus-host disease. CMV infection is a lesser problem after autotransplant. Consequently, prophylaxis with CMV-screened blood products, i.v.IG, and antiviral drugs is not necessary. Treatment of CMV-related interstitial pneumonia remains problematic. Best results to date are with ganciclovir and high-dose i.v.IG.

摘要

相似文献

1
Prevention and treatment of cytomegalovirus infection and disease after bone marrow transplantation in the 1990s.
Bone Marrow Transplant. 1991 Jul;8(1):7-11.
2
Intravenous immunoglobulin and CMV-seronegative blood products for prevention of CMV infection and disease in bone marrow transplant recipients.静脉注射免疫球蛋白和巨细胞病毒血清阴性血液制品用于预防骨髓移植受者的巨细胞病毒感染和疾病。
Bone Marrow Transplant. 1993 Sep;12(3):283-8.
3
Progress in the prevention of cytomegalovirus infection after allogeneic bone marrow transplantation.
Nouv Rev Fr Hematol (1978). 1994;36 Suppl 1:S89-90.
4
Prevention of cytomegalovirus infection following bone marrow transplantation: a randomized trial of blood product screening.骨髓移植后巨细胞病毒感染的预防：血液制品筛查的一项随机试验
Bone Marrow Transplant. 1991 Mar;7(3):227-34.
5
Oral versus intravenous ganciclovir for the prophylaxis of cytomegalovirus disease after allogeneic bone marrow transplantation.
Intern Med J. 2004 Mar;34(3):98-101. doi: 10.1111/j.1444-0903.2004.00550.x.
6
Ganciclovir prophylaxis for cytomegalovirus infection in pediatric allogeneic bone marrow transplant recipients.更昔洛韦预防儿童异基因骨髓移植受者巨细胞病毒感染
Bone Marrow Transplant. 1996 Apr;17(4):589-93.
7
Randomized clinical trial of ganciclovir vs acyclovir for prevention of cytomegalovirus antigenemia after allogeneic transplantation.更昔洛韦与阿昔洛韦预防异基因移植后巨细胞病毒血症的随机临床试验。
Bone Marrow Transplant. 2002 Dec;30(12):945-51. doi: 10.1038/sj.bmt.1703770.
8
[Prevention and treatment of cytomegalovirus infections after graft of allogenic bone marrow].
Nouv Rev Fr Hematol (1978). 1987;29(1):17-21.
9
Cytomegalovirus surveillance and prevention in allogeneic bone marrow transplantation: examination of a preemptive plan of ganciclovir therapy.异基因骨髓移植中巨细胞病毒的监测与预防：更昔洛韦治疗的抢先计划研究
Am J Hematol. 1996 Feb;51(2):104-11. doi: 10.1002/(SICI)1096-8652(199602)51:2<104::AID-AJH2>3.0.CO;2-1.
10
Prophylactic use of ganciclovir for allogeneic bone marrow transplant recipients.对异基因骨髓移植受者预防性使用更昔洛韦。
Bone Marrow Transplant. 1993 Sep;12(3):197-202.

引用本文的文献

1
Adult and Cord Blood-Derived High-Affinity gB-CAR-T Cells Effectively React Against Human Cytomegalovirus Infections.成体和脐血来源的高亲和力 gB-CAR-T 细胞可有效针对人巨细胞病毒感染产生反应。
Hum Gene Ther. 2020 Apr;31(7-8):423-439. doi: 10.1089/hum.2019.149.
2
Signatures of T and B Cell Development, Functional Responses and PD-1 Upregulation After HCMV Latent Infections and Reactivations in Nod.Rag.Gamma Mice Humanized With Cord Blood CD34 Cells.在 Nod.Rag.Gamma 小鼠用人脐带血 CD34 细胞人源化后，巨细胞病毒潜伏感染和再激活后 T 和 B 细胞发育、功能反应和 PD-1 上调的特征。
Front Immunol. 2018 Nov 22;9:2734. doi: 10.3389/fimmu.2018.02734. eCollection 2018.
3
Impact of early CMV reactivation in cord blood stem cell recipients in the current era.
当前时代脐带血干细胞接受者中早期巨细胞病毒再激活的影响。
Bone Marrow Transplant. 2016 Aug;51(8):1113-20. doi: 10.1038/bmt.2016.89. Epub 2016 Apr 4.
4
Alemtuzumab-BEAM as conditioning for allogeneic hematopoietic stem cell transplantation in relapsed/refractory Hodgkin lymphoma: a single-center analysis.阿仑单抗-大剂量化疗联合自体骨髓移植预处理用于复发/难治性霍奇金淋巴瘤的异基因造血干细胞移植：一项单中心分析
J Cancer Res Clin Oncol. 2016 Jun;142(6):1307-14. doi: 10.1007/s00432-016-2134-3. Epub 2016 Feb 26.
5
Long-term follow-up after allogeneic stem cell transplantation in patients with myelodysplastic syndromes or secondary acute myeloid leukemia: a single center experience.骨髓增生异常综合征或继发性急性髓系白血病患者异基因干细胞移植后的长期随访：单中心经验
Wien Klin Wochenschr. 2014 Jan;126(1-2):23-9. doi: 10.1007/s00508-013-0449-5. Epub 2013 Nov 19.
6
CMV reactivation is associated with a lower incidence of relapse after allo-SCT for CML.CMV 再激活与 allo-SCT 后 CML 复发率降低相关。
Bone Marrow Transplant. 2013 Oct;48(10):1313-6. doi: 10.1038/bmt.2013.49. Epub 2013 Apr 8.
7
Autologous stem cell transplantation in adults with metastatic sarcoma of the Ewing family: a single centre experience.成人尤文家族转移性肉瘤的自体干细胞移植：单中心经验。
Wien Klin Wochenschr. 2013 Mar;125(5-6):129-33. doi: 10.1007/s00508-013-0328-0. Epub 2013 Feb 26.
8
Long-term leukemia-free survival after allogeneic marrow transplantation in patients with acute myelogenous leukemia.急性髓性白血病患者异基因骨髓移植后的长期无白血病生存
Ann Hematol. 1996 Feb;72(2):53-9. doi: 10.1007/BF00641308.